Interstitial Lung Disease (ILD) Experts and Advocates Announce Formation of Open Source Imaging Consortium (OSIC)

Global, Not-for-Profit, Collaborative Effort Focuses on Digital Imaging and Machine Learning to Enable Rapid Advances in the Fight against Idiopathic Pulmonary Fibrosis (IPF), Fibrosing ILDs, and Other Respiratory Diseases including Emphysematous Conditions ​

MEDIA CONTACT
​Theresa Hennessey Barcy
theresa@tmhpublicrelations.com
​773-960-7276  

HOLLAND, Mich., Wednesday, May 22, 2019 — An international group of leading experts and advocates in the fight against idiopathic pulmonary fibrosis (IPF), fibrosing interstitial lung diseases (ILDs), and other respiratory diseases including emphysematous conditions announced today the formation of the Open Source Imaging Consortium (OSIC). This global, not-for-profit organization is a cooperative and open source effort between academia, industry and philanthropy to enable rapid advances in the detection and diagnosis of these conditions through digital imaging and machine learning.

OSIC was created on behalf of the countless patients around the world living with idiopathic pulmonary fibrosis and other largely-ignored lung diseases. By bringing together the world’s ‘best in class’ in an open source, collaborative effort, we can collectively speed diagnosis, aid prognosis, and ultimately allow doctors to treat patients more efficiently and effectively.

Elizabeth Estes, Executive Director, OSIC

Read More